Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8715666 | 0.98 | LPAR3 (0.42) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL18837389 | 0.85 | LPAR3 (0.42) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL1906179 | 0.76 | LPAR2 (0.44) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL6831358 | 0.76 | LPAR2 (0.44) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL1933828 | 0.76 | LPAR3 (0.44) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL18184028 | 0.76 | LPAR2 (0.50) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL16311960 | 0.76 | LPAR2 (0.50) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL27094088 | 0.75 | LPAR3 (0.46) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL20500071 | 0.74 | LPAR3 (0.49) | LPAR3LPAR2LPAR1FAAHTRPV1 | |
| SCHEMBL20500069 | 0.74 | LPAR3 (0.49) | LPAR3LPAR2LPAR1FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0946153-A1 | HOMOGENEOUSLY CHARGED PARTICULATE VECTOR AND PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING SAME | BIOVECTOR THERAPEUTICS SA (FR) | 1999-10-06 | — | — | EP | claimed |
| WO-1998029102-A1 | HOMOGENEOUSLY CHARGED PARTICULATE VECTOR AND PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING SAME | BIOVECTOR THERAPEUTICS S.A. (FR) | 1998-07-09 | — | — | WO | claimed |
| US-9238056-B2 | Cyclic peptide and conjugate thereof for binding to keratinocytes | LEO PHARMA A/S (DK) | 2016-01-19 | — | — | US | disclosed |
| US-20140023700-A1 | CYCLIC PEPTIDE AND CONJUGATE THEREOF FOR BINDING TO KERATINOCYTES | LEO PHARMA A/S (DK) | 2014-01-23 | — | — | US | disclosed |
| EP-2678350-A1 | A CYCLIC PEPTIDE AND CONJUGATE THEREOF FOR BINDING TO KERATINOCYTES | Leo Pharma A/S (DK) | 2014-01-01 | — | — | EP | disclosed |
| WO-2012113803-A1 | A CYCLIC PEPTIDE AND CONJUGATE THEREOF FOR BINDING TO KERATINOCYTES | LEO PHARMA A/S (DK) | 2012-08-30 | — | — | WO | disclosed |
| US-20070116767-A1 | Chitosan-microparticles for ifn gene delivery | UNIVERSITY OF SOUTH FLORIDA | 2007-05-24 | — | — | US | disclosed |
| WO-2005105136-A9 | NANOGENE THERAPY FOR CELL PROLIFERATION DISORDERS | UNIV SOUTH FLORIDA (US) | 2006-03-02 | — | — | WO | disclosed |
| US-20050266093-A1 | Nanogene therapy for cell proliferation disorders | UNIVERSITY OF SOUTH FLORIDA | 2005-12-01 | — | — | US | disclosed |
| EP-1594547-A2 | CHITOSAN-MICROPARTICLES FOR IFN GENE DELIVERY | University Of South Florida Research Foundation, Inc. (US) | 2005-11-16 | — | — | EP | disclosed |
| WO-2005105136-A1 | NANOGENE THERAPY FOR CELL PROLIFERATION DISORDERS | UNIVERSITY OF SOUTH FLORIDA (US) | 2005-11-10 | — | — | WO | disclosed |
| WO-2004074314-A2 | CHISTOSAN-MICROPARTICLES FOR IFN GENE DELIVERY | UNIVERSITY OF SOUTH FLORIDA (US) | 2004-09-02 | — | — | WO | disclosed |
| EP-0946153-A1 | HOMOGENEOUSLY CHARGED PARTICULATE VECTOR AND PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING SAME | BIOVECTOR THERAPEUTICS SA (FR) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998029102-A1 | HOMOGENEOUSLY CHARGED PARTICULATE VECTOR AND PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING SAME | BIOVECTOR THERAPEUTICS S.A. (FR) | 1998-07-09 | — | — | WO | disclosed |